Next Article in Journal
Water-Soluble Vitamins and Trace Elements Losses during On-Line Hemodiafiltration
Next Article in Special Issue
Birth Weight and Early Postnatal Outcomes: Association with the Cord Blood Lipidome
Previous Article in Journal
The Brain’s Microvascular Response to High Glycemia and to the Inhibition of Soluble Epoxide Hydrolase Is Sexually Dimorphic
Previous Article in Special Issue
Dyslipidaemia Is Associated with Severe Disease Activity and Poor Prognosis in Ulcerative Colitis: A Retrospective Cohort Study in China
 
 
Article
Peer-Review Record

Association of rs738409 Polymorphism in Adiponutrin Gene with Liver Steatosis and Atherosclerosis Risk Factors in Greek Children and Adolescents

Nutrients 2022, 14(17), 3452; https://doi.org/10.3390/nu14173452
by Eleanna Stasinou 1, Elpida Emmanouilidou-Fotoulaki 2, Maria Kavga 1, Fotini Sotiriadou 1, Alexandros F. Lambropoulos 3, Maria Fotoulaki 1 and Kyriaki Papadopoulou-Legbelou 1,*
Reviewer 1: Anonymous
Reviewer 2:
Nutrients 2022, 14(17), 3452; https://doi.org/10.3390/nu14173452
Submission received: 17 July 2022 / Revised: 17 August 2022 / Accepted: 18 August 2022 / Published: 23 August 2022
(This article belongs to the Special Issue Lipid Metabolism and Relevance to Chronic Disease)

Round 1

Reviewer 1 Report

The Authors investigated the association of adiponutrin gene polymorhism with liver steatosis and atherosclerosis risk factors in a population of 91 Greek children/adolescents.

The study design and analysis are clearly described. Data presentation is clear. The study rationale remains unclear, however, since the results seem to repeat conclusions from ref. 18-20 published over a decade ago. Information on how this study actually contributes to the current state of the art is necessary.

The analysis includes arterial hypertension as one of the risk factors of atheroslerosis. However, hypertension is majorly secondary in the paediatric population. Was diagnostics of hypertension completed in the investigated cohort to ascertain the etiology in the hypertensive subjects?

Also, please explain what was the etiology of liver steatosis in the included subjects if chronic liver disease was an exclusion criterion.

Author Response

Dear Reviewer,

Thank you very much for the time you devoted to our work, as well as for your helpful contribution.

We are now pleased to submit our revision. We have tried to answer all issues.

Please find attached.

We are looking forward to your final decision!

Yours sincerely,

Kyriaki Papadopoulou-Legbelou,MD,PhD

Associate Professor in Paediatrics-Paediatric Cardiology.

Fourth Department of Paediatrics, Medical School, Aristotle University of Thessaloniki ‘Papageorgiou’ General Hospital, Ring Road Nea Efkarpia, Thessaloniki 56403, Greece,

Tel :+302310991463

Fax : +302313323918

Email : [email protected],[email protected]

Author Response File: Author Response.pdf

Reviewer 2 Report

 

The present manuscript authored by Stasinou et al. reports on the association between rs738409 polymorphism in adiponutrin/patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatic steatosis independent of body weight in children and adolescents from northern Greece. Although these observations deserve attention, the study needs clarifying on several issues:

-          The novelty of this work is hampered by the fact that rs738409 polymorphism in the PNPLA3 gene is a critical genetic factor that confers high-risk to NAFLD is a well-known concept (PMIDs: 25641744, 22719876, 25069572, 34147109, and 34106646) even in children (PMIDs: 32811452, 31216264). Authors should emphasize how they study advances the field.

-          How was normality of data tested?

-          Was correction for multiple testing taken into account?

-   Association between PNPLA3 rs738409 variant and diabetes is highly recommended.

-    Authors found that the relationship between rs738409 polymorphism in the PNPLA3 gene and hepatic steatosis is independent of body weight in contrast to other reports in the literature (PMIDs: 28619255, 32561908). This discrepancy should be tackled.

-   This work does not provide an in-depth analysis of the association between genetic variant, NAFLD, and atherosclerosis. Indeed, it was recently published that rs738409 polymorphisms do not relate to distinct measures of subclinical atherosclerosis but associate to ALT levels (PMID: 33105679).

Minor comments

-          Group 1 / 2 / 3 in Tables should be changed to a more meaningful name (e.g.: obese NAFLD, lean NAFLD,…).

 

Author Response

Dear Reviewer,

Thank you very much for the time you devoted to our work, as well as for your helpful contribution.

We are now pleased to submit our revision. We have tried to answer all issues.

Please find attached.

We are looking forward to your final decision!

Yours sincerely,

Kyriaki Papadopoulou-Legbelou,MD,PhD

Associate Professor in Paediatrics-Paediatric Cardiology.

Fourth Department of Paediatrics, Medical School, Aristotle University of Thessaloniki ‘Papageorgiou’ General Hospital, Ring Road Nea Efkarpia, Thessaloniki 56403, Greece,

Tel :+302310991463

Fax : +302313323918

Email : [email protected],[email protected]

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Authors have adequately responded to my comments and followed most of my suggestions. The manuscript in its present form is suitable for publication in Nutrients.

Back to TopTop